Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

Status Completed

Clinical Trial Summary

The purpose of this study is to see if individuals with HIV-infection, particularly those with increased belly fat, have abnormalities in the renin angiotensin aldosterone axis. Renin, angiotensin, and aldosterone are hormones that regulate salt and water balance in the body, and they may also have effects on sugar metabolism and cardiovascular health. There is some evidence that individuals with HIV-associated abdominal fat accumulation may have increased aldosterone, which may contribute to abnormalities in sugar metabolism and increased cardiovascular disease seen in HIV. The purpose of this study is the measure renin, angiotensin, and aldosterone activity, as well as other hormonal axes, in people with and without HIV infection, and with and without increased belly fat. The investigators hypothesize that aldosterone will be increased in HIV-infected individuals compared to those without HIV-infection, and that aldosterone will be further increased in HIV-infected individuals with increased abdominal fat compared to those without abdominal fat accumulation.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01407237
Study type	Observational
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	January 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02489487` - Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500	Phase 1
Completed	`NCT02291081` - A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients
Completed	`NCT01187719` - The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance	Phase 2
Completed	`NCT02413645` - A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy	Phase 1
Completed	`NCT02486133` - Dual Therapy With Boosted Darunavir + Dolutegravir	Phase 3
Completed	`NCT02489435` - Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers	Phase 1
Recruiting	`NCT01397669` - Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection	N/A
Completed	`NCT01606722` - Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy	N/A
Active, not recruiting	`NCT02411071` - Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens	N/A
Completed	`NCT01417949` - Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events	Phase 4